Literature DB >> 23255304

Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.

Tiffany A Greenwood1, Eun-Jeong Joo, Tatyana Shekhtman, A Dessa Sadovnick, Ronald A Remick, Paul E Keck, Susan L McElroy, John R Kelsoe.   

Abstract

Bipolar disorder (BD) and attention deficit hyperactivity disorder (ADHD) exhibit remarkably high rates of comorbidity, as well as patterns of familial co-segregation. Epidemiological data suggests that these disorders either share a common genetic architecture or that ADHD features in BD may represent an etiologically distinct subtype. We previously used the Wender Utah Rating Scale (WURS) to assess ADHD features in BD families and identified three heritable factors relating to impulsivity, mood instability, and inattention. Linkage analysis revealed a LOD score of 1.33 for the inattention factor on 5p15.3 near the dopamine transporter gene (DAT1), which has been associated with both BD and ADHD. Pharmacological evidence also suggests a role for DAT in both disorders. We have now evaluated the association of ten DAT1 variants for the WURS total score and factors in an overlapping sample of 87 BD families. Significant associations for three SNPs were observed across the WURS measures, notably for a SNP in intron 8 with the WURS total score (P = 0.007) and for variants in introns 9 and 13 with mood instability (P = 0.009 and 0.004, respectively). Analysis of an independent sample of 52 BD cases and 46 healthy controls further supported association of the intron 8 variant with mood instability (P = 0.005), and a combined analysis confirmed the associations of this SNP with WURS total score. Impulsivity and mood instability (P = 0.002, 0.007, and 8 × 10(-4), respectively). These data suggest that variants within DAT1 may predispose to a subtype of BD characterized by early prodromal features that include attentional deficits.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255304      PMCID: PMC3904300          DOI: 10.1002/ajmg.b.32108

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  81 in total

Review 1.  Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders.

Authors:  J Biederman; J Newcorn; S Sprich
Journal:  Am J Psychiatry       Date:  1991-05       Impact factor: 18.112

2.  The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.

Authors:  S Fuke; S Suo; N Takahashi; H Koike; N Sasagawa; S Ishiura
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

3.  Evidence of familial association between attention deficit disorder and major affective disorders.

Authors:  J Biederman; S V Faraone; K Keenan; M T Tsuang
Journal:  Arch Gen Psychiatry       Date:  1991-07

4.  Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.

Authors:  M Gill; G Daly; S Heron; Z Hawi; M Fitzgerald
Journal:  Mol Psychiatry       Date:  1997-07       Impact factor: 15.992

Review 5.  Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children.

Authors:  Manpreet K Singh; Melissa P DelBello; Robert A Kowatch; Stephen M Strakowski
Journal:  Bipolar Disord       Date:  2006-12       Impact factor: 6.744

6.  Attention-deficit hyperactivity disorder with bipolar disorder: a familial subtype?

Authors:  S V Faraone; J Biederman; D Mennin; J Wozniak; T Spencer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-10       Impact factor: 8.829

7.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

Authors:  M F Ward; P H Wender; F W Reimherr
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

8.  Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults.

Authors:  Timothy E Wilens; Joseph Biederman; Janet Wozniak; Samantha Gunawardene; Jocelyn Wong; Michael Monuteaux
Journal:  Biol Psychiatry       Date:  2003-07-01       Impact factor: 13.382

9.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.

Authors:  R R Gainetdinov; W C Wetsel; S R Jones; E D Levin; M Jaber; M G Caron
Journal:  Science       Date:  1999-01-15       Impact factor: 47.728

10.  Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity.

Authors:  I D Waldman; D C Rowe; A Abramowitz; S T Kozel; J H Mohr; S L Sherman; H H Cleveland; M L Sanders; J M Gard; C Stever
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

View more
  6 in total

Review 1.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

Review 2.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

Review 3.  The molecular genetic architecture of attention deficit hyperactivity disorder.

Authors:  Z Hawi; T D R Cummins; J Tong; B Johnson; R Lau; W Samarrai; M A Bellgrove
Journal:  Mol Psychiatry       Date:  2015-01-20       Impact factor: 15.992

Review 4.  Neuron membrane trafficking and protein kinases involved in autism and ADHD.

Authors:  Yasuko Kitagishi; Akari Minami; Atsuko Nakanishi; Yasunori Ogura; Satoru Matsuda
Journal:  Int J Mol Sci       Date:  2015-01-30       Impact factor: 5.923

5.  Evaluation of VNTR polymorphisms of dopamine transporter gene and the risk of bipolar disorder in Zahedan, southeast Iran.

Authors:  Mansour Shakiba; Mohammad Hashemi; Salah Mahdar; Zahra Rahbari; Gholamreza Bahari
Journal:  Mol Biol Res Commun       Date:  2017-09

6.  The Influence of 5-HTTLPR, BDNF Rs6265 and COMT Rs4680 Polymorphisms on Impulsivity in Bipolar Disorder: The Role of Gender.

Authors:  Andrea Boscutti; Alessandro Pigoni; Giuseppe Delvecchio; Matteo Lazzaretti; Gian Mario Mandolini; Paolo Girardi; Adele Ferro; Michela Sala; Vera Abbiati; Marco Cappucciati; Marcella Bellani; Cinzia Perlini; Maria Gloria Rossetti; Matteo Balestrieri; Giuseppe Damante; Carolina Bonivento; Roberta Rossi; Livio Finos; Alessandro Serretti; Paolo Brambilla
Journal:  Genes (Basel)       Date:  2022-03-09       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.